Name | Oncogenic or tumor suppressive | Effects | Mechanisms | References |
---|---|---|---|---|
TRIM3 | Suppressive | ↓ Proliferation ↓ Metastasis | G0/G1 cycle arrest | [87] |
TRIM7 | Oncogenic | ↑ Proliferation | Activate DUSP6/p38 pathway | [43] |
Inactivate TP53/p21 | ||||
Suppressive | ↓ Proliferation ↓ Invasion | Inhibit SRC-mTORC1-S6K1 axis | [14] | |
Down-regulate SRC | ||||
TRIM10 | – | – | Block interaction between IFNAR1 and TYK2 | [15] |
TRIM11 | Oncogenic | ↑ Proliferation ↑ Invasion ↑ Metastasis ↓ Autophagy | Down-regulate TP53 | [85] |
Promote EMT Activate PI3K/AKT pathway | [103] | |||
[16] | ||||
Inactivate AMPK pathway | [111] | |||
TRIM16 | Suppressive | ↓ Invasion ↓ Metastasis | Suppress ZEB2 and EMT | [20] |
PML | Oncogenic | ↑Arsenic trioxide resistance ↑ Angiogenesis | Up-regulate ALDH3A1 | [30] |
Metabolic reprogramming | [113] | |||
Suppressive | ↓ Spontaneous HCC ↑ Apoptosis ↓ Liver steatosis | Strengthen DNA damage response and repair | [126] | |
Upregulate TRAIL | [94] | |||
Suppress IL-6-induced STAT3 activation | [132] | |||
Transactivate P53 | ||||
Inhibit cancer stem cells | [119] | |||
Co-activate Fas | [91] | |||
TRIM22 | Suppressive | ↓ HBV | Inhibit core promoter of HBV | |
TRIM23 | Oncogenic | ↑ Proliferation ↓ Apoptosis | Mediate IKKγ ubiquitination | [51] |
TRIM24 | Suppressive | ↓ Spontaneous HCC ↓ Proliferation ↓ Invasion ↓ Metastasis | Attenuate retinoic acid receptor (RARα) | [117] |
Form regulatory complexes with TRIM28 and TRIM33 | [74] | |||
Chromatin remodeling Inhibit VL30-ERV | [77] | |||
Inhibit STAT1 | [76] | |||
TRIM25 | Oncogenic | ↑ Proliferation ↓ Apoptosis ↑ Epirubicin resistance | Activate Keap1-Nrf2 pathway | [97] |
Activate PTEN/AKT pathway | [32] | |||
MAP3K13-TRIM25-FBXW7α-c-Myc protein axis | [88] | |||
Suppressive | ↓ Metastasis ↓ HBV | IFN/IL-27/TRIM25/RIG-1 axis | [124] | |
Down-regulate MTA1 | ||||
TRIM26 | Oncogenic | ↑ HCV | Down-regulate NS5B | [139] |
TRIM28 | Oncogenic | ↑ Warburg effect | Down-regulate FBP1 | [110] |
Suppressive | ↓ Spontaneous HCC ↑ Sexual dimorphic metabolic syndrome | Epigenetic instability Inactivate AKT pathway Inactivate Wnt/β-catenin pathway | [72] | |
ERK1/2-MAPK pathway | [112] | |||
Chromatin remodeling | ||||
TRIM29 | Suppressive | ↓ Proliferation ↓ Invasion ↓ Metastasis | Inactivate Wnt/β-catenin pathway | [44] |
TRIM31 | Oncogenic | ↓ Anoikis ↑ Proliferation ↑ Invasion ↓ Autophagy | Down-regulate TSC1–TSC2 to over-activate mTORC1 pathway | [34] |
Over-activate AMPK pathway | [99] | |||
Down-regulate TP53 | ||||
TRIM32 | Oncogenic | ↑ Proliferation ↑ Oxaliplatin resistance | Accelerate G1 transition | [35] |
TRIM33 | Oncogenic | ↑ Tumor growth (early phase) | Down-regulate SMAD4 to inhibit Smad/TGF-β pathway | [22] |
 | Suppressive | ↓ Spontaneous HCC ↓ Metastasis ↓ Immune escape | Down-regulate SMAD4 to inhibit Smad/TGF-β pathway | [22] |
circTRIM33-12 | [59] | |||
TRIM35 | Suppressive | ↓ Warburg effect | Inhibit PKM2 phosphorylation | |
TRIM37 | Oncogenic | ↑ Metastasis ↑ Sorafenib resistance | Promote EMT | [36] |
Inactivate β-catenin pathway | ||||
Activate AKT pathway | [37] | |||
TRIM44 | Oncogenic | ↑ Proliferation ↓ Apoptosis ↑ Invasion ↑ Migration ↑ Doxorubicin resistance | Accelerate G1/S transition | [38] |
Promote EMT | ||||
Activate NF-κB pathway | ||||
SPATS2/TRIM44/STAT3 axis | [105] | |||
TRIM50 | Suppressive | ↓ Invasion ↓ Metastasis ↑ Anoikis | Down-regulate SNAIL | [24] |
Activate Wnt/β-catenin pathway | ||||
TRIM52 | Oncogenic | ↑ Proliferation ↑ Invasion ↑ Metastasis | Down-regulate PPM1A | [39] |
Inactivate TP53 | ||||
TRIM55 | Suppressive | ↓ Invasion ↓ Metastasis | Down-regulate MMP2 to inhibit EMT | [25] |
TRIM56 | Suppressive | ↑ Proliferation | Down-regulate RBM24 | [26] |
Inactivate Wnt/β-catenin pathway | ||||
TRIM59 | Oncogenic | ↑ Proliferation ↑ Invasion ↑ Metastasis | Down-regulate PPM1B | [40] |
Accelerate G1/S transition | ||||
Promote EMT | [86] | |||
TRIM62 | Oncogenic | ↑ Sorafenib resistance ↑ Proliferation ↑ Invasion | Activate NF-κB pathway | [147] |
TRIM65 | Oncogenic | ↑ Tumor growth ↑ Metastasis | HMGA1/TRIM65/Axin1/β-catenin axis | [83] |
TRIM66 | Oncogenic | ↑ Proliferation ↑ Invasion ↑ Metastasis | Activate Wnt/β-catenin pathway | [101] |
Inhibit EMT | [41] | |||
TRIM71 | Oncogenic | ↑ Proliferation | Inhibit p21 mRNA Non-canonical nonsense-mediated decay | [18] |
Down-regulate AGO2 | [42] | |||
TRIM72 | Suppressive | ↓ Sorafenib resistance | Inhibit RAC1-MAPK pathway | [146] |